Correlation Between Cannassure Therapeutics and Edri El

Can any of the company-specific risk be diversified away by investing in both Cannassure Therapeutics and Edri El at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannassure Therapeutics and Edri El into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannassure Therapeutics and Edri El, you can compare the effects of market volatilities on Cannassure Therapeutics and Edri El and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannassure Therapeutics with a short position of Edri El. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannassure Therapeutics and Edri El.

Diversification Opportunities for Cannassure Therapeutics and Edri El

-0.83

Correlation Coefficient

Cannassure Therapeutics  Edri El

Pay attention - limited upside

The 3 months correlation between Cannassure and Edri is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Cannassure Therapeutics and Edri El in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edri El and Cannassure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannassure Therapeutics are associated (or correlated) with Edri El. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edri El has no effect on the direction of Cannassure Therapeutics i.e., Cannassure Therapeutics and Edri El go up and down completely randomly.

Pair Corralation between Cannassure Therapeutics and Edri El

Assuming the 90 days trading horizon Cannassure Therapeutics is expected to generate 0.96 times more return on investment than Edri El. However, Cannassure Therapeutics is 1.04 times less risky than Edri El. It trades about 0.39 of its potential returns per unit of risk. Edri El is currently generating about -0.06 per unit of risk. If you would invest  69,000  in Cannassure Therapeutics on March 14, 2024 and sell it today you would earn a total of  110,900  from holding Cannassure Therapeutics or generate 160.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cannassure Therapeutics  vs.  Edri El

Cannassure Therapeutics

Risk-Adjusted Performance

30 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Cannassure Therapeutics are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Cannassure Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Edri El

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Edri El has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cannassure Therapeutics and Edri El

The main advantage of trading using opposite Cannassure Therapeutics and Edri El positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannassure Therapeutics position performs unexpectedly, Edri El can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edri El will offset losses from the drop in Edri El's long position.

The idea behind Cannassure Therapeutics and Edri El pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.